ImClone Investigational Site

Newark, New Jersey 07112

0 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma, Non-small Cell Lung Cancer

Studies at this site

• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed